Key facts
- Roon’s last known valuation is $68.0M.
- It has raised $22.5M; the latest was Early Stage VC ($15.0M) in Nov 2024.
- Notable investors include Sequoia Capital, SV Angel, Forerunner Ventures, M13, FirstMark Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Roon
- ·The full record, as it builds
Funding rounds
No funding rounds for Roon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Roon
Developer of a health platform designed for challenging health conditions. The company's platform can be used to talk about multiple diseases, enabling patients to connect with existing care circles with others experiencing a similar journey.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 38
- Website
- roon.com/
- Ownership
- Privately Held (backing)
Roon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Roon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Roon in its N-PORT filings yet. We sweep new filings monthly.